Navigation Links
Elsevier's PharmaPendium(TM) Introduces the FDA Classic Collection
Date:6/2/2009

NEW YORK, June 2 /PRNewswire-FirstCall/ --

- Includes All FDA Drug Approval FOI Documents Through 1991

PharmaPendium (http://www.info.pharmapendium.com/), Elsevier's online resource for authoritative preclinical, clinical and post-marketing drug information, has significantly expanded its coverage of US Food and Drug Administration (FDA) approval documents with the launch of the FDA Classic Collection. This collection contains all available historical FDA approval documents up to and including those issued in 1991 - all indexed and made searchable for the first time in history. With the addition of the FDA Classic Collection, PharmaPendium has become the only integrated, searchable source of all FDA drug approval documents.

The combination of PharmaPendium's current FDA database and the FDA Classic Collection creates an entire searchable library of documents written by the FDA on the approval of drugs and their pharmacokinetics, efficacy and safety. The FDA Classic Collection may be searched simultaneously with the current file (1992-present) or as a discrete database.

"For success within the pharmaceutical industry it's critical to gain and maintain a strong competitive advantage and avoid lost opportunities, lost sales, wasted trials and regulatory recycling. The addition of the FDA Classic Collection to PharmaPendium gives pharmaceutical companies the advantage of being able to gain a unique perspective into the past, enabling them to benefit from information that has not been available for close to 50 years. Users will be able to apply modern analyses tools to these data for the first time, generating new insights. They will no longer encounter information dead ends because every citation to a previous FDA document is now traceable, searchable and viewable," commented Philip MacLaughlin, Senior Product Manager at Elsevier.

Most of the documents in PharmaPendium's FDA Classic Collection were previously available only through direct requests to the FDA/Center for Drug Evaluation and Research Freedom of Information Office and had to be pulled from microfiche. "Now users can locate and search these historic documents in just seconds to uncover regulatory precedents, learn from historic mistakes and successes and apply these lessons to current projects in the drug pipeline," continued MacLaughlin.

The FDA Classic Collection may be added to new or existing PharmaPendium licenses for an additional fee.

About PharmaPendium(TM)

PharmaPendium (http://www.info.pharmapendium.com/), The Essential Resource for Preclinical Safety and Risk Assessment, is a unique online resource that provides access via a single point to searchable and trusted drug information. It covers over 3100 approved drugs, with integrated preclinical, clinical and post-marketing safety data.

PharmaPendium is designed to meet the needs of preclinical safety assessment teams, toxicologists, pharmacokineticists, safety pharmacologists, regulatory affairs staff, pharmacoepidemiologists, clinical researchers and information specialists. It enables text-search of FDA Approval Packages and European Medicines Agency (EMEA) European Public Assessment Reports (EPAR) Approval Documents as well as other data sources. Adverse events and toxicity data are carefully extracted from preclinical and clinical studies from all of these sources. Elsevier offers a broad spectrum of solutions to make processes in drug discovery, preclinical and clinical drug development more efficient, e.g. CrossFire and Reaxys, EMBASE and PharmaPendium. More information can be found at http://www.elsevierforindustry.com.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult ( http://www.mdconsult.com), Scopus (http://www.info.scopus.com/), bibliographic databases and online reference works.

Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    PharmaPendium is a trademark of Elsevier Inc.

    Media Contact:

    Tom Reller
    Elsevier
    +1-212-462-1912
    t.reller@elsevier.com



'/>"/>
SOURCE Elsevier
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Delta Dental of Illinois Introduces Smile Smart For Your Health
2. Highmark Blue Cross Blue Shield Introduces New Health Plan Comparison Tool for Consumers
3. Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers
4. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
5. GladRags Introduces the Moon Cup - An Environmentally-Sound and Safe Alternative to Disposable Feminine Hygiene Products!
6. Triveris Introduces Personal Health Record with Built-in Health Advisor
7. Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region
8. Mecklenburg EMS Introduces Most-Advanced Situational Training in America for Emergency Medical Personnel
9. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
10. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
11. ThermoTx Introduces New Mobile Stimulation (TENS) Product Line for On the Go Therapy and Pain Relief
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... ... Refresh Restore Reward”: is a story of struggle and how trouble often happens for ... cofounded the Free Spirit Bible Church and currently serves as the church’s Director of ... to come over before the baby had to go back to her grandparents. In ...
(Date:9/25/2017)... ... 25, 2017 , ... “Grandpa's Visit”: a tender and relatable tale of ... others. “Grandpa's Visit” is the creation of published author, Beverly Brumfield, gifted writer and ... the character in her book. She shares, “Mr. Rice is struggling to keep up ...
(Date:9/25/2017)... ... September 25, 2017 , ... Netmail, Inc . and ... Hadron Data Auditing and eDiscovery services to healthcare organizations as ... Hadron solution in a HIPAA/HITRUST Azure Cloud at the Microsoft Ignite #MSIgnite conference in ...
(Date:9/25/2017)... ... September 25, 2017 , ... Azadian Group, a commercial lender ... downtown Los Angeles, to service existing clients in the Western U.S. and to capitalize ... seeing an ever-increasing amount of business demand west of the Mississippi and we are ...
(Date:9/25/2017)... ... 25, 2017 , ... Emerald Ash Borers kill Ash trees in as little as ... Philadelphia region. A video by Rob Nagy, ISA Certified Arborist at Giroud Tree and ... several are dead or showing signs of decline from Emerald Ash Borers, two Ash trees ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/22/2017)... Sept. 22, 2017  As the latest Obamacare repeal ... Bill Cassidy (R-LA) and Lindsey Graham ... the medical device industry is in an odd place. ... the 2.3% excise tax on medical device sales passed ... want covered patients, increased visits and hospital customers with ...
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical ... device is now successfully helping those with the widespread ... Fibromyalgia diagnosed Amanda in Essex, England ... and washing my hair, experiencing no sleep at all, ... painful spasm… I cannot recommend [the AVACEN 100] enough, ...
Breaking Medicine Technology: